Skip to main content
. 2023 Nov 30;109(5):1460–1468. doi: 10.3324/haematol.2023.284453

Figure 3.

Figure 3.

Progression-free and overall survival of all patients with on-time and delayed cell infusion. (A) Progression-free survival (PFS) of all patients with on-time and delayed cell infusion. (B) Overall survival (OS) of all patients with on-time and delayed cell infusion.